Pegenzileukin, a Selectively Pegylated IL-2 Analog, Enhances Anti-Tumor Function of NK Cells without Activating Regulatory T Cells

被引：0
|
作者：
Oja, Anna [1 ]
Kasic, Nada-Katarina [1 ]
Cesonyte, Ieva [1 ]
Franciszkiewicz, Katarzyna [2 ]
Calvet, Loreley [2 ]
Sidhu, Sukhvinder [2 ]
Kunert, Andre [1 ]
Igarashi, Robert [1 ]
机构：
[1] Sanofi, Oncol Res, Amsterdam, Netherlands
[2] Sanofi, Oncol Res, Vitry Sur Seine, France
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1776
引用
收藏
页码：828 / 828
页数：1
相关论文
共 50 条
  • [21] TARGETING WILDTYPE IL-2 TO CD8 T CELLS INDUCES POTENT ANTI-TUMOR IMMUNE RESPONSES AND DECREASES IL-2 MEDIATED TOXICITY
    Ramasamy, Selvi
    Nardozzi, Joanathan
    Boi, Shannon
    Swain, Joanna
    Coyle, Anthony
    Gulla, Stefano
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1141 - A1141
  • [22] Enhancement of IL-2 and IFN-γ expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo
    Wang, Guan
    Zhao, Jian
    Liu, Jianwen
    Huang, Yongping
    Zhong, Jian-Jiang
    Tang, Wen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (06) : 864 - 870
  • [23] Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer:: IL-2 promotes development of anti-tumor memory T cells in vivo
    Hughes, DPM
    Baskar, D
    Urban, FA
    Friedman, MS
    Braun, TM
    McDonagh, KT
    CYTOTHERAPY, 2005, 7 (05) : 396 - 407
  • [24] Differential Effects of Denileukin Diftitox IL-2 Immunotoxin on NK and Regulatory T Cells in Nonhuman Primates
    Yamada, Yohei
    Aoyama, Akihiro
    Tocco, Georges
    Boskovic, Svjetlan
    Nadazdin, Ognjenka
    Alessandrini, Alessandro
    Madsen, Joren C.
    Cosimi, A. Benedict
    Benichou, Gilles
    Kawai, Tatsuo
    JOURNAL OF IMMUNOLOGY, 2012, 188 (12): : 6063 - 6070
  • [25] Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells
    Carmenate, Tania
    Ortiz, Yaquelin
    Enamorado, Michel
    Garcia-Martinez, Karina
    Avellanet, Janet
    Moreno, Ernesto
    Graca, Luis
    Leon, Kalet
    JOURNAL OF IMMUNOLOGY, 2018, 200 (10): : 3475 - 3484
  • [26] IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
    Lykhopiy, Valentina
    Malviya, Vanshika
    Humblet-Baron, Stephanie
    Schlenner, Susan M.
    GENES AND IMMUNITY, 2023, 24 (05) : 248 - 262
  • [27] Synergistic Killing of Tumor Cells by IL-2 activated NK Cells and Tumor-specific CTLs
    Yu, Shaohong
    Wynn, Juliet
    Fischer, Andrew
    Rich, Julia
    Lotze, Michael T.
    Basse, Per H.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 950 - 951
  • [28] Anti-tumor effect by dendritic cells stimulated with IL-2 in OT-1 model
    Yang, Qin
    Herberman, Ronald B.
    Lotze, Michael T.
    Kalinski, Pawel
    Basse, Per H.
    FASEB JOURNAL, 2008, 22
  • [29] IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
    Valentina Lykhopiy
    Vanshika Malviya
    Stephanie Humblet-Baron
    Susan M. Schlenner
    Genes & Immunity, 2023, 24 (5): : 248 - 262
  • [30] Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
    Li, Yu
    Zhang, Cangang
    Jiang, Aimin
    Lin, Anqi
    Liu, Zaoqu
    Cheng, Xiangshu
    Wang, Wanting
    Cheng, Quan
    Zhang, Jian
    Wei, Ting
    Luo, Peng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
12345